Sinovac Biotech, Ltd. revenue for the last year amounted to 448.27 M USD, the most of which — 448.27 M USD — came from its highest performing source at the moment, Biotechnology, the year earlier bringing 1.49 B USD. The greatest contribution to the revenue figure was made by China — last year it brought Sinovac Biotech, Ltd. 381.06 M USD, and the year before that — 1.12 B USD.